全球立体定位手术设备市场规模（按产品类型、应用、区域范围和预测）

立体定位手术设备的市场规模及预测

立体定位手术设备市场规模在 2024 年价值 191.5 亿美元，预计到 2032 年将达到 277.3 亿美元，2026 年至 2032 年的复合年增长率为 4.74%。

• 立体定位手术设备是一种现代医疗设备，可在手术过程中实现精准定位，特别适用于治疗脑部疾病、肿瘤和某些神经系统疾病。这些技术利用核磁共振成像 (MRI)、 电脑断层扫描和 X 光等影像技术，提供3D座标系，使外科医生能够精确定位和操作脑部特定区域及其他解剖结构。立体定位手术的应用包括立体定位放射放射线手术、切片检查和深部脑部刺激电极植入，所有这些手术都提供了微创选择，可以缩短患者康復时间并改善手术效果。
• 由于影像技术、机器人系统和人工智慧的进步，立体定位手术的潜力令人乐观。这些进步将提高手术的准确性和有效性，并使更具挑战性的手术更加安全。
• 神经系统疾病盛行率的上升和人口老化预计将推动对这些设备的需求。与远端医疗和远距手术功能的整合有望扩大立体定位治疗的覆盖范围，使医疗资源匮乏的地区更容易获得专科治疗。

立体定位手术设备的全球市场动态

影响全球立体定位手术设备市场的关键市场动态是：

关键市场驱动因素

• 神经系统疾病盛行率不断上升：神经系统疾病盛行率不断上升，推动了立体定位手术设备市场的发展，因为人们对精准诊断和治疗方案选择的需求日益增长。根据世界卫生组织 (WHO) 报告，神经系统疾病是全球伤残调整生命年 (DALY) 减少的主要原因，也是第二大死因。根据《2019 年全球疾病负担研究》，这些疾病在全球造成了 2.8 亿 DALY。日益加重的疾病负担需要更精准、恢復时间更短的新型手术方案，推动了对先进立体定位手术技术的需求。
• 微创手术的日益普及：微创手术的日益普及推动了对立体定位设备的需求，该设备具有许多优势，例如恢復时间更短、併发症率更低。根据美国整形外科医师协会的数据，2000年至2020年间，微创美容手术成长了174%。 《神经外科杂誌》的一项研究显示，脑肿瘤手术中微创手术的使用率从2010年的2%上升到2019年的12%。这一发展标誌着外科手术技术朝着更精准、创伤更小的方向发展，从而增加了对用于辅助此类治疗的先进立体定位技术的需求。
• 成像技术的进步：影像技术的进步显着提高了立体定位手术的准确性和有效性，从而推动了立体定位手术器械市场的成长。经济合作暨发展组织(OECD) 报告称，OECD 国家每百万人口拥有的核磁共振造影系统数量从 2013 年的 15.5 台增加到 2019 年的 17.4 台，而同期 CT 扫描仪数量则从 24.1 台增加到 27.8 台。这些影像技术的进步为外科医生提供了更精确的解剖讯息，从而可以进行更有效的干预并改善患者的预后。随着影像技术的进步，利用这些突破的先进立体定位器的需求可能会上升。

主要挑战

• 病患安全问题：儘管立体定位手术有许多优势，但其准确性可能会受到病患移动和解剖差异等因素的影响。此类安全问题导致外科医生犹豫不决。解决这些问题将推动市场创新，鼓励开发更复杂的成像技术和即时监控系统，从而提高准确性和患者安全性。
• 熟练专业人员短缺：对能够理解并操作立体定位手术最新技术的熟练人员的需求日益增长。缺乏训练有素的员工可能会阻碍该行业的扩张。这一困境促使人们投资于教育计画和培训项目，最终将培养出更多称职的员工，并使更多医疗机构能够有效地运用这些新的手术技术。
• 技术淘汰：快速的技术进步可能导致现有的立体定位设备过时，这给那些在这些系统上投入大量资金的医疗机构带来了淘汰的担忧。儘管这充满挑战，但它激励製造商继续研发结合最新趋势的下一代技术，以不断提升立体定位手术的功能和疗效。

主要趋势：

• 机器人辅助手术的应用日益广泛：立体定位手术中机器人器械的使用日益普及，提高了手术的精确度和控制力。机器人技术可以改善手术效果并缩短恢復时间。随着医院寻求采用创新技术来保持市场竞争力、改善患者照护并取得更好疗效，最终吸引更多患者，这一趋势正在推动市场扩张。
• 个人化医疗方法：个人化医疗运动正在影响立体定位手术设备市场。治疗方法。随着越来越多的医疗保健专业人员采用此策略，它将推动对能够适应个人化治疗方案的先进立体定位手术设备的需求，从而刺激技术创新并拓展市场前景。
• 医疗基础设施投资不断增加：许多国家正在增加医疗基础设施投资，以提高外科手术能力，并提供新医疗技术的取得途径。随着医院和诊所寻求设施现代化并扩展服务范围，这一趋势正在推动立体定位手术技术的使用。不断增加的投资正在刺激对先进手术设备的需求，从而推动整体市场成长。

目录

第一章：全球立体定位手术设备市场简介

• 市场概览
• 研究范围
• 先决条件

第二章执行摘要

第三章：已验证的市场研究调查方法

• 资料探勘
• 验证
• 第一手资料
• 资料来源列表

第四章立体定位手术设备全球市场展望

• 概述
• 市场动态
  • 驱动程式
  • 限制因素
  • 机会
• 波特五力模型
• 价值链分析

第五章全球立体定位手术设备市场（依产品类型）

• 概述
• 伽玛刀
• 直线加速器（linac）
• 质子束
• 电脑刀

第六章立体定位手术设备全球市场（按应用）

• 概述
• 动静脉畸形治疗
• 脑肿瘤治疗
• 癫痫治疗
• 帕金森氏症
• 三叉神经痛

7. 全球立体定位手术设备市场（按地区）

• 概述
• 北美洲
  • 美国
  • 加拿大
  • 墨西哥
• 欧洲
  • 德国
  • 英国
  • 法国
  • 其他欧洲国家
• 亚太地区
  • 中国
  • 日本
  • 印度
  • 其他亚太地区
• 世界其他地区
  • 拉丁美洲
  • 中东和非洲

第八章全球立体定位手术设备市场的竞争格局

• 概述
• 各公司市场排名
• 主要发展策略

第九章 公司简介

• Ion Beam Applications SA
• Mevion Medical Systems
• Varian Medical Systems
• Monteris Medical
• Elekta AB
• Micromar
• Accuracy Incorporated
• Inomed
• Alliance Oncology
• Medical AG

第十章 附录

• 相关调查

Stereotactic Surgery Devices Market Size and Forecast

Stereotactic Surgery Devices Market size was valued at USD 19.15 Billion in 2024 and is projected to reach USD 27.73 Billion by 2032, growing at a CAGR of 4.74% from 2026 to 2032.

• Stereotactic surgery devices are modern medical instruments that allow for accurate targeting during surgical procedures, particularly in the treatment of brain diseases, tumors, and certain neurological conditions. These technologies use imaging techniques like MRI, CT scans, and X-rays to provide a three-dimensional coordinate system, allowing surgeons to precisely pinpoint and operate on specific parts of the brain or other anatomical structures. Stereotactic surgery applications include stereotactic radiosurgery, biopsy treatments, and deep brain stimulation electrode implantation, all of which offer minimally invasive choices that reduce patient recovery time and enhance surgical outcomes.
• The potential of stereotactic surgery equipment seems optimistic, thanks to advances in imaging technology, robotic systems, and artificial intelligence. As these technologies advance, they are projected to improve the precision and efficacy of surgical treatments, enabling more difficult procedures to be performed safely.
• The increasing prevalence of neurological disorders, as well as the aging population, are expected to drive up demand for these devices. Integration with telemedicine and remote surgery capabilities may potentially broaden the scope of stereotactic treatments, making specialized care more accessible in underprivileged areas.

Global Stereotactic Surgery Devices Market Dynamics

The key market dynamics that are shaping the global stereotactic surgery devices market include:

Key Market Drivers:

• Increasing Prevalence of Neurological Disorders: The increased prevalence of neurological disorders is driving the stereotactic surgery devices market, as there is a greater need for precise diagnosis and treatment choices. The World Health Organization (WHO) reports that neurological illnesses are the largest cause of disability-adjusted life years (DALYs) and the second highest cause of mortality worldwide. According to the Global Burden of Disease Study 2019, these illnesses account for 280 million DALYs worldwide. This growing burden needs new surgical procedures that provide more accuracy and shorter recovery times, driving demand for sophisticated stereotactic surgery technologies.
• Growing Adoption of Minimally Invasive Surgical Procedures: The increased use of less invasive surgical procedures is driving up demand for stereotactic surgery instruments, which provide several benefits such as shorter recovery times and lower complication rates. According to the American Society of Plastic Surgeons, minimally invasive cosmetic operations increased by 174% between 2000 and 2020. Research in the Journal of Neurosurgery found that the usage of minimally invasive procedures for brain tumor surgery grew from 2% in 2010 to 12% in 2019. This development indicates a shift toward more accurate and less traumatic surgical methods, which is increasing the demand for advanced stereotactic technologies that aid such treatments.
• Advancements in Imaging Technologies: Imaging technology advancements are considerably improving the precision and efficacy of stereotactic procedures, resulting in market growth for stereotactic surgical instruments. The Organization for Economic Cooperation and Development (OECD) reported an increase in MRI units per million population in OECD countries from 15.5 in 2013 to 17.4 in 2019, while CT scanners increased from 24.1 to 27.8 during the same period. These advancements in imaging technologies allow surgeons to gain more precise anatomical information, resulting in more effective interventions and better patient outcomes. As imaging technology advances, there will be an increased demand for advanced stereotactic devices that take advantage of these breakthroughs.

Key Challenges:

• Patient Safety Concerns: Despite their benefits, the precision of stereotactic procedures might be hampered by factors such as patient movement or anatomical differences. These safety issues can cause hesitation among surgeons. Resolving these problems encourages the development of more complex imaging technologies and real-time monitoring systems that increase accuracy and patient safety, promoting market innovation.
• Shortage of Skilled Professionals: There is an increasing demand for skilled individuals who can operate and understand the latest technologies used in stereotactic surgery. The shortage of trained staff has the potential to hinder industry expansion. This difficulty promotes investment in educational initiatives and training programs, which will eventually assist in producing a more competent staff and ensure that more facilities can efficiently use these new surgical techniques.
• Technological Obsolescence: Rapid technological improvements might render existing stereotactic devices obsolete, raising worries about obsolescence for medical facilities that make significant investments in these systems. While this is a difficulty, it motivates manufacturers to continue researching and developing next-generation technologies that combine the most recent advances, hence continuously improving the capabilities and effectiveness of stereotactic procedures.

Key Trends:

• Increased Use of Robotic-Assisted Surgery: The use of robotic devices in stereotactic surgery is gaining popularity, improving precision and control during treatments. Robotics improves surgery results and shortens recuperation periods. This trend is propelling market expansion as hospitals attempt to implement innovative technologies in order to remain competitive, improve patient care, and achieve better results, ultimately attracting more patients.
• Personalized Medicine Approach: The personalized medicine movement is having an impact on the market for stereotactic surgery devices. Tailoring therapy to unique patient features can result in improved surgical outcomes. As more healthcare practitioners embrace this strategy, there is a greater demand for advanced stereotactic devices capable of accommodating tailored treatment programs, which drives innovation and expands market prospects.
• Increased Investment in Healthcare Infrastructure: Many countries are investing in healthcare infrastructure to improve surgical capabilities and provide access to new medical technologies. This trend encourages the use of stereotactic surgery technologies as hospitals and clinics look to modernize their facilities and expand their service offerings. Increased investment drives up demand for sophisticated surgical devices, resulting in total market growth.

Global Stereotactic Surgery Devices Market Regional Analysis

Here is a more detailed regional analysis of the global stereotactic surgery devices market:

North America:

• The North American region currently dominates the stereotactic surgery equipment market, thanks to its advanced healthcare infrastructure, major research institutes, and large patient population suffering from neurological disorders. The high prevalence of neurological events, such as strokes, contributes greatly to this demand; the Centers for Disease Control and Prevention (CDC) says that roughly 795,000 strokes occur in the United States each year, many of which could benefit from stereotactic therapies. The National Brain Tumor Society believes that approximately 700,000 Americans have a primary brain tumor, with a projected 89,000 new diagnoses in 2024. The growing reliance on stereotactic radiosurgery for brain malignancies drives the expansion of this market sector.
• The North American stereotactic surgery devices market is expected to maintain its dominant position. The increase in the number of neurosurgeons from 3,500 in 2012 to over 5,700 in 2024 represents a developing field that will increasingly rely on stereotactic technology. The increase in the number of neurosurgeons from 3,500 in 2012 to over 5,700 in 2024 represents a developing field that will increasingly rely on stereotactic technology. The US Food and Drug Administration (FDA) has fostered innovation by approving new devices, such as 7D Surgical's MvIGS system in 2021, demonstrating continued progress in this field. As the population ages, with forecasts predicting that by 2030, one in every five Americans will be 65 or older, the demand for effective neurological treatment alternatives is likely to increase, propelling market expansion even further.

Asia Pacific:

• The Asia Pacific region is rapidly emerging as the fastest-growing market for stereotactic surgery devices, owing to a combination of factors such as the rising prevalence of neurological diseases, rising disposable income, increased awareness of advanced treatment options, and significant government initiatives aimed at improving healthcare infrastructure. The World Health Organization (WHO) highlights neurological illnesses as a prominent cause of disability and mortality in this region, with the Global Burden of Disease Study 2019 estimating 150 million disability-adjusted life years (DALYs) in Southeast Asia. This urgent need for efficient treatment solutions is driving up demand for stereotactic surgery as an advanced intervention for illnesses such as brain tumors, which are becoming more common.
• The Asia Pacific stereotactic surgery devices market is poised for significant expansion. This expansion is further aided by government programs such as China's "Healthy China 2030" plan, which intends to increase healthcare expenditures and technology adoption, and India's National Health Policy 2017, which aims to raise public health expenditure.
• Rapid urbanization and rising disposable incomes in countries such as China and India are also driving market growth, as more people have access to innovative medical treatments. As knowledge of these new solutions rises, along with continued improvements in healthcare infrastructure, the Asia Pacific stereotactic surgical devices market is likely to continue its rapid expansion, potentially outpacing other global markets.

Global Stereotactic Surgery Devices Market: Segmentation Analysis

The Global Stereotactic Surgery Devices Market is Segmented on the basis of Product Type, Application, And Geography.

Stereotactic Surgery Devices Market, By Product Type

• Gamma Knife
• Line Accelerator (LINAC) Machines
• Proton Beam
• CyberKnife

Based on Product Type, the market is bifurcated into Gamma Knife, Line Accelerator (LINAC) Machines, Proton Beam, and CyberKnife. Gamma Knife technology is currently dominant due to its proven effectiveness in treating brain tumors and other neurological problems. The Gamma Knife, known for its precision in delivering large doses of radiation while limiting damage to surrounding healthy tissues, has become a preferred choice for neurosurgeons, contributing to its widespread use. CyberKnife is emerging as the fastest-growing segment, thanks to its adaptability and capacity to treat tumors in a variety of sites across the body. Unlike older methods, CyberKnife employs real-time imaging and robotic technology, making non-invasive treatments more appealing to patients and healthcare providers. This expansion is aided by advances in robotic technology and increased knowledge of minimally invasive treatment choices.

Stereotactic Surgery Devices Market, By Application

• Arteriovenous Malformations Treatment
• Brain Tumor Treatment
• Epilepsy
• Parkinson's Disease

Based on Application, the market is segmented into Arteriovenous Malformations Treatment, Brain Tumor Treatment, Epilepsy, and Parkinson's Disease. The Brain Tumor sector is currently a leading due to the high occurrence of primary and metastatic brain tumors, which require precision treatment options such as stereotactic radiosurgery. This segment benefits from modern technology that improve treatment outcomes while minimizing dangers. The Epilepsy segment is expanding at a rapid pace, owing to increased understanding and adoption of stereotactic approaches for treating intractable seizures. As more patients look for alternatives to medication, the need for less invasive techniques such stereotactic surgery to target seizure foci is fast increasing, driving growth in this market.

Stereotactic Surgery Devices Market, By Geography

• North America
• Europe
• Asia Pacific
• Rest of the World
• On the basis of Geography, the Global Stereotactic Surgery Devices Market is classified into North America, Europe, Asia Pacific, and the Rest of the World. The North American region currently dominates the market for stereotactic surgery devices due to its advanced healthcare infrastructure, strong research base, and large patient population. However, the Asia-Pacific region is witnessing the fastest rise, owing to an increase in the frequency of neurological disorders, rising disposable income, and more awareness of improved treatment alternatives. This region is also benefiting from positive government initiatives and investments in healthcare infrastructure.

Key Players

The "Global Stereotactic Surgery Devices Market" study report will provide valuable insight with an emphasis on the global market. The major players in the market are Ion Beam Applications S.A., Mevion Medical Systems, Varian Medical Systems, Monteris Medical, Elekta AB, Micromar, Accuracy Incorporated, Inomed, Alliance Oncology, and Medical AG. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.

Our market analysis also entails a section solely dedicated to such major players wherein our analysts provide an insight into the financial statements of all the major players, along with product benchmarking and SWOT analysis. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.

• Stereotactic Surgery Devices Market Recent Developments
• In February 2024, Elekta enhanced its Asian market position with the acquisition of Premier Business Inter (PBI), a Thai distributor.

TABLE OF CONTENTS

1 INTRODUCTION OF GLOBAL STEREOTACTIC SURGERY DEVICES MARKET

• 1.1 Overview of the Market
• 1.2 Scope of Report
• 1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH

• 3.1 Data Mining
• 3.2 Validation
• 3.3 Primary Interviews
• 3.4 List of Data Sources

4 GLOBAL STEREOTACTIC SURGERY DEVICES MARKET OUTLOOK

• 4.1 Overview
• 4.2 Market Dynamics
  • 4.2.1 Drivers
  • 4.2.2 Restraints
  • 4.2.3 Opportunities
• 4.3 Porters Five Force Model
• 4.4 Value Chain Analysis

5 GLOBAL STEREOTACTIC SURGERY DEVICES MARKET, BY PRODUCT TYPE

• 5.1 Overview
• 5.2 Gamma knife
• 5.3 Line accelerator (LINAC) machines
• 5.4 Proton beam
• 5.5 CyberKnife

6 GLOBAL STEREOTACTIC SURGERY DEVICES MARKET, BY APPLICATION

• 6.1 Overview
• 6.2 Arteriovenous malformations treatment
• 6.3 Brain tumor treatment
• 6.4 Epilepsy
• 6.5 Parkinson's disease
• 6.6 Trigeminal Neuralgia

7 GLOBAL STEREOTACTIC SURGERY DEVICES MARKET, BY GEOGRAPHY

• 7.1 Overview
• 7.2 North America
  • 7.2.1 U.S.
  • 7.2.2 Canada
  • 7.2.3 Mexico
• 7.3 Europe
  • 7.3.1 Germany
  • 7.3.2 U.K.
  • 7.3.3 France
  • 7.3.4 Rest of Europe
• 7.4 Asia Pacific
  • 7.4.1 China
  • 7.4.2 Japan
  • 7.4.3 India
  • 7.4.4 Rest of Asia Pacific
• 7.5 Rest of the World
  • 7.5.1 Latin America
  • 7.5.2 Middle East & Africa

8 GLOBAL STEREOTACTIC SURGERY DEVICES MARKET COMPETITIVE LANDSCAPE

• 8.1 Overview
• 8.2 Company Market Ranking
• 8.3 Key Development Strategies

9 COMPANY PROFILES

• 9.1 Ion Beam Applications S.A.
  • 9.1.1 Overview
  • 9.1.2 Financial Performance
  • 9.1.3 Product Outlook
  • 9.1.4 Key Developments
• 9.2 Mevion Medical Systems
  • 9.2.1 Overview
  • 9.2.2 Financial Performance
  • 9.2.3 Product Outlook
  • 9.2.4 Key Developments
• 9.3 Varian Medical Systems
  • 9.3.1 Overview
  • 9.3.2 Financial Performance
  • 9.3.3 Product Outlook
  • 9.3.4 Key Developments
• 9.4 Monteris Medical
  • 9.4.1 Overview
  • 9.4.2 Financial Performance
  • 9.4.3 Product Outlook
  • 9.4.4 Key Developments
• 9.5 Elekta AB
  • 9.5.1 Overview
  • 9.5.2 Financial Performance
  • 9.5.3 Product Outlook
  • 9.5.4 Key Developments
• 9.6 Micromar
  • 9.6.1 Overview
  • 9.6.2 Financial Performance
  • 9.6.3 Product Outlook
  • 9.6.4 Key Developments
• 9.7 Accuracy Incorporated
  • 9.7.1 Overview
  • 9.7.2 Financial Performance
  • 9.7.3 Product Outlook
  • 9.7.4 Key Developments
• 9.8 Inomed
  • 9.8.1 Overview
  • 9.8.2 Financial Performance
  • 9.8.3 Product Outlook
  • 9.8.4 Key Developments
• 9.9 Alliance Oncology
  • 9.9.1 Overview
  • 9.9.2 Financial Performance
  • 9.9.3 Product Outlook
  • 9.9.4 Key Developments
• 9.10 Medical AG
  • 9.10.1 Overview
  • 9.10.2 Financial Performance
  • 9.10.3 Product Outlook
  • 9.10.4 Key Developments

10 Appendix

• 10.1 Related Research